Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.

Annals of surgical oncology - 1 Jan 2025

Shim Veronica, Karlea Audrey, Brenman Leslie Manace, Gul Jamila, Hoodfar Elizabeth, Chan Tracy D, Engeman Poline C, Sheldon Vanessa M, Thorne-Hadfield Deirdre M, Odele Patience, Vuong Brooke, McEvoy Jennifer, Chang C K, Kotak Dinesh, Habel Laurel A

Abstract excerpt

BACKGROUND: This study evaluated a new mainstream genetic testing pathway for hereditary cancer, with expanded eligibility for early-stage breast cancer patients. METHODS: The study compared multigene panel (62 genes) germline testing uptake and results for breast cancer patients at 4 pilot sites (n = 502 patients) and 10 non-pilot sites (n = 1792 patients) within Kaiser Permanente Northern California from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to California

Share to Follow-Up Studies

Share to Genetic Counseling

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Pilot Projects

Source

Open in PubMed Open full text

Identifiers

PMID: 39292401
DOI: 10.1245/s10434-024-16223-7
PMCID: PMC11659365

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.PMID 39292401Read ↗

Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.Semantic proximity Read ↗

Germline Genetic Testing Among Women ≤ 45 Years of Age with Ductal Carcinoma In Situ Versus Invasive Breast Cancer in a Large Integrated Health Care System.Semantic proximity Read ↗

Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery SystemSemantic proximity Read ↗

Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations.Semantic proximity Read ↗

Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to ActionSemantic proximity Read ↗

Consideration for Multigene Panel Testing Outside of Cancer-Specific Genetic Testing.Semantic proximity Read ↗

Clinical Integration of Germline Findings from a Tumor Testing Precision Medicine ProgramSemantic proximity Read ↗

Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.Semantic proximity Read ↗

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathwaySemantic proximity Read ↗

Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon's practice in a large US Academic Center.Semantic proximity Read ↗

An implementation study of the service model for genetic risk-based stratified breast cancer screening – Estonian results of the BRIGHT projectSemantic proximity Read ↗

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.